As evidence, he points to the acquisition of neurological therapy business Reata Pharmaceuticals by Biogen for $US7.3 billion ($11.2 billion) in July 2023.By comparison, Neuren had a market value of $2.9 billion on February 12 and De Silva says Reata’s lead drug, Skyclarys, treats a condition two-and-a-half times less prevalent than Rett syndrome.
Daybue is exceeding forecasts for initial adoption and patients are tolerating the treatment regimen above expectations,” says Smith. “More excitingly, the next drug [at the clinical trial stage] has produced positive topline results with the phase 2 trial.”Hashan De Silva, founder and managing partner at medtech investment fund KP Rx, reckons Neuren’s success makes it a takeover target for big pharma. De Silva formerly worked as a healthcare analyst at broker CLSA and hedge fund Karst Peak.
Neuren: Sophie Smith, an investment analyst for the SGH Medical Technology Fund, believes the biotech company will continue its stunning rise – 1609 per cent higher over the past five years. Neuren has commercialised a drug named Daybue to treat neurological disorder Rett syndrome in children and has other drugs in clinical trials.
- Forums
- ASX - By Stock
- NEU
- Merck to acquire Prometheus in a US$ 10.8 b deal
Merck to acquire Prometheus in a US$ 10.8 b deal, page-93
-
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$19.97 |
Change
0.070(0.35%) |
Mkt cap ! $2.552B |
Open | High | Low | Value | Volume |
$20.22 | $20.44 | $19.85 | $4.194M | 209.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2772 | $19.93 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.99 | 3310 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 441 | 19.840 |
1 | 979 | 19.830 |
1 | 26 | 19.810 |
3 | 1278 | 19.800 |
2 | 4391 | 19.790 |
Price($) | Vol. | No. |
---|---|---|
20.000 | 150 | 1 |
20.030 | 441 | 2 |
20.050 | 1010 | 2 |
20.090 | 979 | 1 |
20.100 | 157 | 2 |
Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |